CATALYST PHARMACEUTICALS, INC. CPRX
CATALYST PHARMACEUTICALS, INC. statistics & valuation
Market cap$3.9B
P / E18.0×
P / S6.5×
P / B4.0×
P / FCF18.5×
Net margin36.4%
Return on equity22.5%
FCF margin35.4%
Return on capital26.9%
Graham number$16.84
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($16.84); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 43.8% | 39.7% | 21.8% | 47.5% | 37.2% | 34.7% | 31.1% | -7059.0% | — | — |
| Net margin | 36.4% | 33.3% | 17.9% | 38.8% | 28.0% | 63.0% | 31.2% | -6800.7% | — | — |
| FCF margin | 35.4% | 48.7% | 36.0% | 54.2% | 42.1% | 37.8% | 33.8% | -5247.9% | — | — |
| Return on assets | 19.4% | 19.2% | 15.2% | 22.1% | 16.6% | 39.0% | 28.4% | -56.3% | -21.6% | -43.3% |
| Return on equity | 22.5% | 22.5% | 18.4% | 27.7% | 19.1% | 44.2% | 36.4% | -67.0% | -22.7% | -46.0% |
| Current ratio | 6.08 | 5.17 | 2.88 | 5.57 | 7.76 | 7.00 | 4.62 | 5.80 | 19.97 | 19.79 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.